Latest news about Bandaram Pharma Packtech
Bandaram Pharma Packtech Adjusts Subsidiary's Textbook Order Value to Rs 27.71 Crore from Rs 37.44 Crore
Bandaram Pharma Packtech
20.48
-0.85(-3.98%)
Company Performance:
View Company Insights1D-3.98%
1M+13.78%
6M-16.82%
1Y-34.11%
5Y-10.29%
More news about Bandaram Pharma Packtech
31May 26
Bandaram Pharma reports FY26 profit, auditors flag subsidiary issues
Bandaram Pharma Packtech Limited reported a consolidated net profit of ₹44.81 lakh for the financial year ended March 31, 2026, while standalone operations recorded a net loss of ₹115.91 lakh. The board approved the audited financial results on May 30, 2026. Statutory auditors M/s. M.M. Reddy & Co. issued an unmodified opinion on standalone results but a modified opinion on consolidated results due to accounting irregularities at subsidiary VSR Paper and Packaging Limited, specifically regarding the netting off of trade receivables and payables amounting to ₹1,240.80 lakh without sufficient documentation. The board also appointed M/s. MGR & Co. as internal auditors for FY 2026-27.
29May 26
Bandaram unit secures Rs 3.87 crore order for textbook materials
VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech Limited, has secured a work order worth Rs.3,86,85,410 from M/s S. A. Printers for supplying raw materials for printing textbooks. The order is for the academic year 2026-27 with an execution period from June to August 2026. The disclosure confirms the order is from a domestic entity and is not a related party transaction.
21May 26
Bandaram board to meet on May 30 to consider FY26 results
Bandaram Pharma Packtech Limited will hold a board meeting on May 30, 2026, to consider the audited financial statements for the quarter and year ended March 31, 2026. The meeting will also review the standalone and consolidated audit reports.
11Apr 26
Bandaram Pharma Packtech Limited Submits Q4FY26 Compliance Certificate Under SEBI Regulations
Bandaram Pharma Packtech Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 11.04.2026. The certificate, issued by RTA Cameo Corporate Services Limited, confirms proper processing of dematerialisation requests, certificate mutilation procedures, and timely register updates for the quarter ended 31.03.2026.
03Apr 26
Bandaram Pharma Packtech Submits EGM Notice Under Regulation 30 for April 27
Bandaram Pharma Packtech has formally submitted its EGM notice to BSE under Regulation 30, scheduling the meeting for April 27, 2026. The agenda includes appointing Mr. Eswar Reddy Putturu as Independent Director and approving material related party transactions worth ₹100 crores with subsidiary VSR Paper and Packaging Limited, comprising ₹50 crores for sales/purchase and ₹50 crores for corporate guarantee.
13Feb 26
Bandaram Pharma Packtech Announces Q3FY26 Results Under Regulation 33 Compliance
Bandaram Pharma Packtech Limited announced its Q3FY26 financial results under SEBI Regulation 33 compliance, showing contrasting performance between standalone and consolidated operations. While standalone operations reported a net loss of Rs. 21.14 lakhs, consolidated operations achieved a net profit of Rs. 34.95 lakhs, primarily driven by subsidiary performance including VSR Paper & Packaging Limited and Craftsmart Products Private Limited.
30Jan 26
Bandaram Pharma Packtech Limited Announces Board Changes with New Director Appointment and Resignation
Bandaram Pharma Packtech Limited announced board changes effective 30.01.2026, appointing Mr. Eswar Reddy Putturu as Additional Non-Executive Independent Director for a 5-year term and accepting Mrs. Priyanka Agarwal's resignation due to personal reasons. The new director brings MBA expertise in finance and marketing, while the outgoing director also served on boards of Midland Polymers Limited and Cura Technologies Limited. All regulatory compliance requirements under SEBI regulations have been fulfilled.
14Nov 25
Bandaram Pharma Packtech Reports Q2 FY26 Loss of Rs. 34.74 Lakhs Amid Revenue Decline
Bandaram Pharma Packtech Limited reported a net loss of Rs. 34.74 lakhs for Q2 FY26, compared to a profit of Rs. 67.19 lakhs in Q2 FY25. Standalone revenue fell by 89.6% to Rs. 32.93 lakhs. Despite reducing expenses by 75.8%, the company couldn't offset the revenue decline. Half-yearly results show a total income of Rs. 109.50 lakhs and a net loss of Rs. 61.63 lakhs. Consolidated performance was slightly better with revenue of Rs. 1,372.48 lakhs and a net profit of Rs. 6.02 lakhs for Q2 FY26.
07Nov 25
Bandaram Pharma Packtech Promoters Acquire Additional Shares Through Preferential Allotment
Bandaram Pharma Packtech Limited announced a major share acquisition by its promoters. Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025. This increased the company's equity share capital from Rs. 12.00 crores to Rs. 17.97 crores. After the acquisition, the promoter group's holdings include Prajitha Bandaram (486,480 shares), Satyavathi Bandaram (1,880,000 shares), B Premsai Reddy (1,880,000 shares), and M. Seetharama Reddy (112,500 shares). The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers.
05Sept 25
Bandaram Pharma Packtech Reappoints Chairman, Sets AGM Date for September 2025
Bandaram Pharma Packtech's board has approved the reappointment of Mr. Deepak Reddy Bandaram as Chairman and Managing Director for three years, subject to shareholder approval. The company's AGM for FY 2024-25 is scheduled for September 29, 2025, via video conference. The board also approved the Directors' Report for FY 2024-25.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Suraksha Diagnostic
Krsnaa Diagnostics
3B BlackBio DX
One Global Service Provider
Health X Platform
1,950.40
(+0.43%)
1,475.00
(-1.76%)
562.30
(-1.75%)
547.10
(-0.22%)
663.40
(-1.57%)
355.05
(+2.31%)
553.60
(+3.66%)
1,622.70
(+2.39%)
534.15
(-1.98%)
285.05
(-0.04%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
